Stevanato Group (NYSE:STVN) Issues FY 2026 Earnings Guidance

Stevanato Group (NYSE:STVN) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.690-0.730 for the period, compared to the consensus earnings per share estimate of 0.730. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Stevanato Group Stock Performance

STVN opened at €17.50 on Thursday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.30 and a current ratio of 1.89. Stevanato Group has a 52-week low of €13.91 and a 52-week high of €28.00. The firm has a market cap of $5.30 billion, a P/E ratio of 30.70, a price-to-earnings-growth ratio of 1.18 and a beta of 0.57. The business’s fifty day moving average is €17.79 and its 200-day moving average is €21.75.

Analyst Upgrades and Downgrades

STVN has been the topic of a number of analyst reports. KeyCorp reduced their price objective on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday. Wall Street Zen downgraded shares of Stevanato Group from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. Jefferies Financial Group set a $17.50 price target on shares of Stevanato Group in a research report on Tuesday, February 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. Finally, Morgan Stanley initiated coverage on Stevanato Group in a research note on Monday, December 1st. They set an “equal weight” rating and a $24.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Trending Headlines about Stevanato Group

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Strong top‑line and mix shift: FY2025 revenue grew 7% (9% cc) with record sales from higher‑margin “high‑value solutions,” supporting margin expansion and longer‑term revenue mix improvement. BusinessWire Release
• Positive Sentiment: Management set a 2026 revenue target (up to ~€1.308B) and expects high‑value solutions to reach ~48% of sales — a strategic shift that can raise long‑term margins and justify a premium multiple if execution continues. Seeking Alpha Article
• Positive Sentiment: Market reaction to the quarterly release was strong in early trading — several outlets report the stock rallied on the results and outlook, reflecting investor enthusiasm for growth and the high‑value pivot. Investing.com Report
• Neutral Sentiment: Q4 / FY2025 detail availability: management hosted an earnings call and released a slide deck and press release; the call transcript provides operational color on capacity, product mix and customer demand that investors should review. Earnings Call Transcript
• Neutral Sentiment: Mixed media/analyst takes: commentary ranges from “time to reassess after rebound” to deeper analysis of whether the high‑value shift can sustain margin improvement — useful for determining conviction but not immediate price drivers. Yahoo Finance
• Neutral Sentiment: Press/earnings summaries vary on EPS beat/miss — some services report a modest beat while others cite a small miss versus consensus; the disparity is largely due to different currency/ADR conversions and rounding. Investors should use company filings for the definitive numbers. MarketBeat / Slides
• Negative Sentiment: FY‑2026 EPS guidance came in at €0.690–€0.730, with the midpoint slightly below some street estimates — this conservative EPS range likely capped upside after the initial rally and introduced short‑term investor caution. (Guidance disclosed in company materials and call.)
• Negative Sentiment: Near‑term execution risk: moving a larger share of revenue into higher‑value solutions is positive structurally but requires sustained customer wins and margin delivery; any slowdown or margin pressure would weigh on the stock given the current valuation (PE ~30.7). Investing.com Analysis

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. GW&K Investment Management LLC lifted its stake in shares of Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after acquiring an additional 1,055 shares during the last quarter. State of Wyoming increased its holdings in Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after purchasing an additional 2,353 shares in the last quarter. Quantbot Technologies LP bought a new position in Stevanato Group in the third quarter valued at about $68,000. Tower Research Capital LLC TRC raised its position in Stevanato Group by 1,268.7% in the second quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock valued at $112,000 after purchasing an additional 4,250 shares during the last quarter. Finally, Walleye Capital LLC acquired a new stake in shares of Stevanato Group during the fourth quarter valued at about $214,000.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.